Fcγ receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor α-blocking agents

2005 ◽  
Vol 52 (9) ◽  
pp. 2693-2696 ◽  
Author(s):  
Zuhre Tutuncu ◽  
Arthur Kavanaugh ◽  
Nathan Zvaifler ◽  
Maripat Corr ◽  
Reena Deutsch ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Treatment Outcomes ◽  
Inflammatory Arthritis ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Receptor Type ◽  
Fcγ Receptor ◽  
Blocking Agents ◽  
Factor Α ◽  
Necrosis Factor

scholarly journals Fcγ receptor type IIIA genotype and response to tumor necrosis factor α–blocking agents in patients with rheumatoid arthritis

2007 ◽  
Vol 56 (2) ◽  
pp. 448-452 ◽  
Author(s):  
Alf Kastbom ◽  
Johan Bratt ◽  
Sofia Ernestam ◽  
Jon Lampa ◽  
Leonid Padyukov ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Receptor Type ◽  
Fcγ Receptor ◽  
Blocking Agents ◽  
Type Iiia ◽  
Factor Α ◽  
Necrosis Factor

scholarly journals Peptidylarginine Deiminase 4 Contributes to Tumor Necrosis Factor α-Induced Inflammatory Arthritis

2014 ◽  
Vol 66 (6) ◽  
pp. 1482-1491 ◽  
Author(s):  
Miriam A. Shelef ◽  
Jeremy Sokolove ◽  
Lauren J. Lahey ◽  
Catriona A. Wagner ◽  
Eric K. Sackmann ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Inflammatory Arthritis ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Peptidylarginine Deiminase ◽  
Peptidylarginine Deiminase 4 ◽  
Factor Α ◽  
Necrosis Factor

scholarly journals Tumor necrosis factor α and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis

2009 ◽  
Vol 60 (9) ◽  
pp. 2644-2654 ◽  
Author(s):  
Georg Schett ◽  
Marina Stolina ◽  
Denise Dwyer ◽  
Debra Zack ◽  
Stefan Uderhardt ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Inflammatory Arthritis ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Spur Formation ◽  
Factor Α ◽  
Bony Spur ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document